United States · FDA National Drug Code directory

Duloxetine Delayed-Release

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-0392_e8fe3c0e-a41b-4e12-a4c7-71c8f6e37de5
Product NDC
71335-0392
Form
CAPSULE, DELAYED RELEASE PELLETS
Composition / generic term
DULOXETINE HYDROCHLORIDE
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20140611
Source listing expiry
20261231

Source-listed ingredients

  • DULOXETINE HYDROCHLORIDE — 30 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (71335-0392-1) · 71335-0392-1
  • 60 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (71335-0392-2) · 71335-0392-2
  • 28 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (71335-0392-3) · 71335-0392-3
  • 6 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (71335-0392-4) · 71335-0392-4
  • 90 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (71335-0392-5) · 71335-0392-5
  • 15 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (71335-0392-6) · 71335-0392-6
  • 180 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (71335-0392-7) · 71335-0392-7
  • 120 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (71335-0392-8) · 71335-0392-8

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →